|
EIF4B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.38764563675886E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
2.816200E-02 |
| Normal-vs-Stage3 |
1.312000E-02 |
| Normal-vs-Stage4 |
3.588800E-01 |
| Stage1-vs-Stage2 |
4.915900E-03 |
| Stage1-vs-Stage3 |
1.553380E-04 |
| Stage1-vs-Stage4 |
1.87259999995248E-06 |
| Stage2-vs-Stage3 |
9.186200E-01 |
| Stage2-vs-Stage4 |
2.546600E-01 |
| Stage3-vs-Stage4 |
2.587400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.62374583065639E-12 |
| Normal-vs-AfricanAmerican |
3.403800E-02 |
| Normal-vs-Asian |
1.028970E-01 |
| Caucasian-vs-AfricanAmerican |
3.936400E-01 |
| Caucasian-vs-Asian |
4.459200E-01 |
| AfricanAmerican-vs-Asian |
3.307600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.64820046499869E-10 |
| Normal-vs-Female |
1.47680000006645E-07 |
| Male-vs-Female |
8.718200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.723840E-01 |
| Normal-vs-Age(41-60Yrs) |
1.98659977357352E-10 |
| Normal-vs-Age(61-80Yrs) |
1.19309999657702E-08 |
| Normal-vs-Age(81-100Yrs) |
6.328000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.459800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.222600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.172200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.768000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.588200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.340770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.197600E-03 |
| Normal-vs-Grade 2 |
1.11022302462516E-16 |
| Normal-vs-Grade 3 |
1.57681999999326E-05 |
| Normal-vs-Grade 4 |
3.177400E-01 |
| Grade 1-vs-Grade 2 |
6.770400E-01 |
| Grade 1-vs-Grade 3 |
1.348640E-01 |
| Grade 1-vs-Grade 4 |
6.218900E-04 |
| Grade 2-vs-Grade 3 |
1.376410E-03 |
| Grade 2-vs-Grade 4 |
8.51740011853508E-10 |
| Grade 3-vs-Grade 4 |
3.837400E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
1.932330E-02 |
| ccA subtype-vs-ccB subtype |
1.08040021373768E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.38699990066038E-10 |
| Normal-vs-N1 |
6.849800E-01 |
| N0-vs-N1 |
2.912300E-02 |
|
|
